57
Social Media in Pharma Making it Happen Gary Monk

Pharma Health Social Media Facebook Cases

Embed Size (px)

DESCRIPTION

Presentation at the SMI Social Media congress, January 2014. A case comparison of 4 Pharma companies efforts on Facebook. GSK, Pfizer, Novartis and Boehringher Ingelheim. Some useful learnings around Health Care Social Media.

Citation preview

Page 1: Pharma Health Social Media Facebook Cases

Social Media in PharmaMaking it Happen

Gary Monk

Page 2: Pharma Health Social Media Facebook Cases

Social Media in PharmaMaking it Happen

Gary Monk

Presentation includes speaker notes on slides

Page 3: Pharma Health Social Media Facebook Cases

@garymonk

garywmonk

[email protected]

Page 4: Pharma Health Social Media Facebook Cases

@garymonk

garywmonk

[email protected] have delivered social media programmes inside and outside of pharma and understand the challenges, I hope I can share some useful learning’s!

Page 5: Pharma Health Social Media Facebook Cases
Page 6: Pharma Health Social Media Facebook Cases

This presentation centres around Facebook, it is the biggest social media platform however the learning’s can be transferred to almost any social media platform or programme

Page 7: Pharma Health Social Media Facebook Cases
Page 8: Pharma Health Social Media Facebook Cases

There are other pharma companies on Facebook. These ‘FAIRLY BIG 4’ corporate pages have been compared and contrasted. The Top 2 pages by likes are J&J and Bayer. A subject for another presentation...

Page 9: Pharma Health Social Media Facebook Cases
Page 10: Pharma Health Social Media Facebook Cases

This presentation is not about beating up ANY of these companies, rather identifying and sharing valuable learnings

Page 11: Pharma Health Social Media Facebook Cases
Page 12: Pharma Health Social Media Facebook Cases

ALL of these companies deserve recognition for being brave and actually going out there into the social space!

Page 13: Pharma Health Social Media Facebook Cases
Page 14: Pharma Health Social Media Facebook Cases
Page 15: Pharma Health Social Media Facebook Cases

Terms and conditions are warm, welcoming and friendly. The language is fun, yet explains clearly WHAT is allowed, in terms of comments and WHY

Page 16: Pharma Health Social Media Facebook Cases
Page 17: Pharma Health Social Media Facebook Cases

Example of Boehringer using human language to outline community rules

Page 18: Pharma Health Social Media Facebook Cases
Page 19: Pharma Health Social Media Facebook Cases

Boehringer have an interesting approach curating exciting health technology news and innovations in combination with their own news

Page 20: Pharma Health Social Media Facebook Cases

“So we're changing from just Boehringer Ingelheim 'boring pharma company', just giving out its news, to become more of a news source.”

Quote via PM Live on why they have taken this approach

Page 21: Pharma Health Social Media Facebook Cases

Approach

The content approach thus combines a blend of internal and external news

Page 22: Pharma Health Social Media Facebook Cases

Responding

Boehringer respond quickly to questions in a friendly way

Page 23: Pharma Health Social Media Facebook Cases

Responding

Responses are considered, compliant but warm

Page 24: Pharma Health Social Media Facebook Cases

Engaging

Boehringer like to ask questions and they usually get a good response

Page 25: Pharma Health Social Media Facebook Cases

Infographics

Note Boehringers use of infographics and the split between German and English language

Page 26: Pharma Health Social Media Facebook Cases
Page 27: Pharma Health Social Media Facebook Cases
Page 28: Pharma Health Social Media Facebook Cases

• Nice friendly introductory explanation as to what can and can’t be discussed• Very transparent list, If you choose

to list these in your own page, consider how you word these to ensure they remain friendly• Consider the resources required to

deal with non-english or non-local language. What language do your stakeholders want to express themselves in?

Page 29: Pharma Health Social Media Facebook Cases

Good transparency from Novartis, asking employees to ‘announce’ themselves in Social Media

Page 30: Pharma Health Social Media Facebook Cases

Approach

Novartis produces engaging content primarily internally focused, around the company

Page 31: Pharma Health Social Media Facebook Cases

Responding

Novartis are very good at responding quickly. In this case they had to hide a product mention for compliance reasons however responded back with clear next steps for support

Page 32: Pharma Health Social Media Facebook Cases

Infographics

Novartis also use engaging infographics

Page 33: Pharma Health Social Media Facebook Cases

Employee support

Novartis employees strongly support the Facebook site and help to dilute any negativity

Page 34: Pharma Health Social Media Facebook Cases
Page 35: Pharma Health Social Media Facebook Cases

GSK are clear on what is allowable on their page and explain why

Page 36: Pharma Health Social Media Facebook Cases
Page 37: Pharma Health Social Media Facebook Cases

ApproachGSK talk primarily about themselves, they use interesting hooks to generate engagement such as celebrity endorsement i.e. F1 driver Jenson Button. They also had a great sponsorship campaign of the London 2012 Olympics

Page 38: Pharma Health Social Media Facebook Cases

Historic negative comments

In a previous blog I highlighted historic negative comments to GSK. These seem to have reduced. It is not clear if they becoming less prominent or if GSK are taking a stronger line in terms of moderating them

Page 39: Pharma Health Social Media Facebook Cases

Non English comments welcome

GSK have a global approach with comments allowed in multiple languages

Page 40: Pharma Health Social Media Facebook Cases

Strong employee support

Employees are very positive. Even assuming the ‘KILLERS’ comment is negative and not simply an off topic reference to the band of the same name, it is diluted by the positivity cultivated on the page.

Page 41: Pharma Health Social Media Facebook Cases

Responding

A really nice example of GSK responding quickly and openly to questions about a negative GSK news story. It is very important to get the responses to these constructive questions right, and of course to not hide these sort of comments!

Page 42: Pharma Health Social Media Facebook Cases

Responding

Another example of a typical response although a little slower

Page 43: Pharma Health Social Media Facebook Cases
Page 44: Pharma Health Social Media Facebook Cases
Page 45: Pharma Health Social Media Facebook Cases

Pfizer are clear what is and what is not permissible. They do suggest people reach out to them which is a nice touch

Page 46: Pharma Health Social Media Facebook Cases

Approach

Pfizer use strong news articles that people tend to interact with. These are very much focused on Pfizer

Page 47: Pharma Health Social Media Facebook Cases

Unanswered questions

Page 48: Pharma Health Social Media Facebook Cases

Unanswered questions

There are several recent questions asked of Pfizer on their page and they elect not to reply. It is important to consider your approach. Usually it is a convoluted legal process that prevents responses being given to questions in a timely manner, rather than a desire not to talk to people

Page 49: Pharma Health Social Media Facebook Cases

Strong employee support

Employees are extremely ‘loving’ to Pfizer. It would be good to see at least some discussion here with differing view points

Page 50: Pharma Health Social Media Facebook Cases
Page 51: Pharma Health Social Media Facebook Cases

Different companies, different tones and styles however some common principles on using corporate social media

Page 52: Pharma Health Social Media Facebook Cases

Page likes

43367 95748 92989 84545

All companies have significant numbers of page likes

Page 53: Pharma Health Social Media Facebook Cases

Average post likes

99 153 171 347

Boehringer have a significant number of average post likes, partly driven by rich media such as video and curating exciting and relevant healthcare news

Page 54: Pharma Health Social Media Facebook Cases

Average post comments

4.4 4.6 5.5 4.3

All companies are generating a similar amount of comments with GSK slightly ahead

Page 55: Pharma Health Social Media Facebook Cases

# posts last 3 months

25 26 25 37

All companies are generating good interactions with their posts and could consider increasing the volume of quality content that they post

Page 56: Pharma Health Social Media Facebook Cases

Learnings

• Human and friendly ‘engagement policy’• Defined process for managing comments• Rich content schedule• Approval processes to support a quick &

human response• Stakeholder value?• Consider approach to multiple languages

Page 57: Pharma Health Social Media Facebook Cases

@garymonk

garywmonk

[email protected]

Questions?

Please get in touch